Drawing for GENTLEPLAN

USPTO serial 99493401

GENTLEPLAN

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
AURAND, KYLE C
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with GENTLEPLAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina L. Martini

Christina L. Martini Dechert LLP444 West Lake Street, Suite 2100Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology and treatment planning for surgical and non-surgical interventions of nonmelanoma skin cancer as well as other skin conditions via medical imaging modalities, photosonic, photoacoustic, reflective confocal microscopy, tomosynthesis, high resolution ultrasound, and high resolution photography; Treatment Planning Systems (TPS) comprising computer hardware and medical imaging apparatus, and featuring embedded computer software for computer vision, diagnostic imaging guidance, pattern recognition, and decision support with integrated safety protocols for treatment accuracy and patient safety optimizationACTIVE—
010Hybrid medical imaging apparatus comprised of confocal microscopes, photo-acoustic sensors, high-frequency medical ultrasound apparatus, LiDAR apparatus for medical imaging purposes, and optical medical imaging apparatus for use in the fields of radiotherapy and Mohs surgical intervention image-guidance and diagnosticsACTIVE—
042Scientific research and development in the field of pathology using artificial intelligence (AI), machine vision, and machine learning algorithms to analyze images for medical and scientific research diagnostic purposes for use by consultants, clinicians, patients, and caregivers in healthcare; application services provider (ASP) featuring computer artificial intelligence software for image analysis for use in the healthcare field, namely, software for accessing and viewing patient pathology images and information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing on-line non-downloadable artificial intelligence software for image analysis for use in the healthcare field, namely, for accessing and viewing patient pathology image information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing online non-downloadable software for using mobile and distributed computing data and application functionality access and meshing for use in both IGSRT and Mohs surgery, evaluation and lesion analysis and monitoring, for use in the field of treatment planning; Providing online non-downloadable software for patient-centric geo-location-based workflow and data distribution and management; Providing online non-downloadable cloud computing software for accessing and viewing patient pathology images and information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing virtual computer systems and virtual computer environments through cloud computing in the field of healthcare; Providing temporary use of online non-downloadable cloud computing software using artificial intelligence for accessing and viewing patient pathology images and information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing temporary use of online non-downloadable computer software for communication between computers over a local network for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology; Providing temporary use of on-line non-downloadable computer application software for cloud computing services for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology; Providing online non-downloadable cloud computing software for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Aug 11, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 16, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 21, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 21, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 21, 2026XAECEXAMINER'S AMENDMENT ENTERED—
May 21, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
May 21, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
May 21, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 12, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 22, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 21, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 21, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2026DOCKASSIGNED TO EXAMINER—
Mar 18, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 18, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 12, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance